Corticotropin-releasing hormone neurons in hypertensive patients are activated in the hypothalamus but not in the brainstem

Journal of Comparative Neurology

Volumn 503, Issue 1, 2007, Pages 148-168

  Goncharuk, Valeri D ^a,b   Buijs, Ruud M ^b,c   Swaab, Dick F ^b  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c UNIVERSIDAD VERACRUZANA   (Mexico)

Author keywords

Cardiovascular disease; HPA axis; Hypothalamic paraventricular nucleus; Neuroendocrine regulation of circulation; Suprachiasmatic nucleus

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; HORMONE ANTIBODY; NEUROTENSIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOPRESSIN;

AMYGDALOID NUCLEUS; ARTICLE; BRAIN STEM; CONTROLLED STUDY; HORMONE ACTION; HORMONE RELEASE; HUMAN; HYPERTENSION; HYPOTHALAMUS; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; NERVE CELL; NERVE FIBER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; BRAIN STEM; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; HYPERTENSION; HYPOTHALAMUS; MALE; MIDDLE AGED; NEURONS; NEUROSECRETORY SYSTEMS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; REFERENCE VALUES; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; SUPRACHIASMATIC NUCLEUS; TISSUE DISTRIBUTION;

EID: 34347404889     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.21387     Document Type: Article

References (84)

1. al'Absi M, Wittmers LE. 2003. Enhanced adrenocorticortical responses to stress in hypertension-prone men and women. Ann Behav Med 25:25-33.
2. al'Absi M, Lovallo WR, McKey BS, Pincomb GA. 1994. Borderline hypertensives produce exaggregated adrenocortical responses to mental stress. Psychosom Med 56:245-250.
3. Austin MC, Janovsky JE, Murphy HA. 2003. Increased corticotrophin- releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men. Mol Psychiatry 8:324-332.
4. Bernal-Mizrachi C, Weng S, Feng C, Finck BN, Knutsen RH, Leone TC, Coleman T, Mecham RP, Kelly DP, Semenkovich CF. 2003. Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice. Nat Med 9:1069-1075.
5. Bissette G, Klimek V, Pan J, Stockmeier C, Ordway G. 2003. Elevated concentrations of CRF in the locus coeruleus of depressed subjects. Neuropsychopharmacology 28:1328-1335.
6. Blessing WW. 2004. Lower brain stem regulation of visceral, cardiovascular, and respiratory function. In: Paxinos G, Mai J, editors. The human nervous system. London: Elsevier. p 464-478.
7. Borsody MK, Weiss JM. 1996. Influence of corticotrophin-releasing hormone on electrophysiological activity of locus coeruleus neurons. Brain Res 724:149-168.
8. Boudaba C, Szabo K, Tasker JG. 1996. Physiological mapping of local inhibitory inputs to the hypothalamic paraventricular nucleus. J Neurosci 16:7151-7160.
9. Buckley TM, Schatzberg AF. 2005. Review: on the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab 90:3106-3114.
10. Campbell RE, Grove KL, Smith MS. 2003. Distribution of corticotrophin releasing hormone receptor immunoreactivity in the rat hypothalamus: coexpression in neuropeptide Y and dopamine neurons in the arcuate nucleus. Brain Res 973:223-232.
11. Chazov EI, Oganov RG, Pogosova GV, Shal'nova SA, Romasenko LV, Shchurov DV. 2006. Depression in cardiological practice: pilot results from a multicenter clinico-epidemiological trial in hypertensive patients with ischemic heart disease (kordinata). Ter Arkh 78:38-44.
12. Covar RA, Leung DYM, McCormick D, Steelman J, Zeitler P, Spahn JD. 2000. Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma. J Allergy Clin Immunol 106:651-659.
13. Cummings S, Elde R, Ells J, Lindall A. 1983. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study. J Neurosci 3:1355-1368.
14. Dai J, Swaab DF, Buijs RM. 1997. Distribution of vasopressin and vasoactive intestinal polypeptide (VIP) fibers in the human hypothalamus with special emphasis on suprachiasmatic nucleus efferent projections. J Comp Neurol 383:397-414.
15. Dampney RAL, Horiuchi J, Killinger S, Sheriff MJ, Tan PSP, McDowall LM. 2005. Long-term regulation of arterial blood pressure by hypothalamic nuclei: some critical questions. Clin Exp Pharmacol Physiol 32:419-425.
16. Davidson K, Jonas BS, Dixon KE, Markovitz JH. 2000. Do depression symptoms predict early hypertension incidence in young adults in the CARDIA study? Arch Intern Med 160:1495-1500.
17. Dellmann D, Bugnon C, Bresson JL, Gouget A, Cardot J, Clavequin MC, Hadjiyiassemis M. 1984. The CRF neuron: immunohistochemical study. Peptides 5(suppl 1):19-33.
18. De Souza EB, Grigoriadis DE. 2000. Multiple brain corticotrophin- releasing factor receptors and binding protein. In: Quirion R, Bjoerklund A, Hoekfelt T, editors. Handbook of chemical neuroanatomy, vol 16: Peptide receptors, Part 1. Amsterdam: Elsevier. p 477-508.
19. Dickinson LD, Papadopoulos SM, Hoff JT. 1993. Neurogenic hypertension related to basilar impression. J Neurosurg 79:924-928.
20. Filipovsky J, Ducimetiere P, Eschwege E, Richard JL, Rosselin G, Claude JR. 1996. The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men. J Hypertens 2:229-235.
21. Fisher LA. 1993. Central actions of corticotrophin-releasing factor on autonomic nervous activity and cardiovascular functioning. Ciba Found Symp 172:243-253.
22. Foote SL, Cha CI. 1988. Distribution of corticotrophin-releasing-factor- like immunoreactivity in brainstem of two monkey species (Saimiri sciureus and Macaca fascicularis): an immunohistochemical study. J Comp Neurol 276:239-264.
23. Goncharuk VD, van Heerikhuize J, Dai JP, Swaab DF, Buijs RM. 2001. Neuropeptide changes in the suprachiasmatic nucleus in primary hypertension indicate functional impairment of the biological clock. J Comp Neurol 431:320-330.
24. Goncharuk V, Van Heerikhuize J, Swaab DF, Buijs RM. 2002. Paraventricular nucleus of the human hypothalamus in primary hypertension: activation of corticotropin-releasing hormone neurons. J Comp Neurol 443:321-331.
25. Hermes MLHJ, Coderre EM, Buijs RM, Renauld LP. 1996. GABA and glutamate mediate rapid neurotransmission from suprachiasmatic nucleus to hypothalamic paraventricular nucleus in rat. J Physiol (Lond) 496:749-757.
26. Horiuchi J, McAllen RM, Allen AM, Killinger S, Fontes MAP, Dampney RAL. 2004. Descending vasomotor pathways from the dorsomedial hypothalamic nucleus: role of medullary raphe and RVLM. Am J Physiol Regul Integr Comp Physiol 287:R824-R832.
27. Huitinga I, Erkut ZA, van Beurden D, Swaab DF. 2004. Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions. Ann Neurol 55:37-45.
28. Imaki T, Naruse M, Harada S, Chikada N, Nakajima K, Yoshimoto T, Demura H. 1998. Stress-induced changes of gene expression in the paraventricular nucleus in spontaneously hypertensive rats. J Neuroendocrinol 10:635-643.
29. Kalsbeek A, van der Vliet J, Buijs RM. 1996. Decrease of endogeneous vasopressin release necessary for expression of the circadian rise in plasma corticosterone: a reverse microdialysis study. J Neuroendocrinol 8:299-307.
30. Kelly JJ, Mangos G, Williamson PM, Whitworth JA. 1998. Cortisol and hypertension. Clin Exp Pharm Physiol Suppl:S51-S56.
31. 8]-vasopressin and oxytocin neurons in the goat hypothalamus. J Vet Med Sci 59:621-628.
32. Kirby LG, Rice KC, Valentino RJ. 2000. Effects of corticotrophin- releasing factor on neuronal activity in the serotoninergic dorsal raphe nucleus. Neuropsychopharmacology 22:148-162.
33. Koutcherov Y, Mai JK, Ashwell KWS, Paxinos G. 2000. Organization of the human paraventricular hypothalamic nucleus. J Comp Neurol 423:299-318.
34. Koutcherov Y, Huang X-F, Halliday G, Paxinos G. 2004. Organization of human brain stem nuclei. In: Paxinos G, Mai J, editors. The human nervous system. London: Elsevier. p 267-320.
35. Krout KE, Kawano J, Mettenleiter TC, Loewy AD. 2002. CNS inputs to the suprachiasmatic nucleus of the rat. Neuroscience 110:73-92.
36. Krukoff TL, MacTavish D, Jhamandas JH. 1999. Hypertensive rats exhibit heightened expression of corticotrophin-releasing factor in activated central neurons in response to restrain stress. Mol Brain Res 65:70-79.
37. Ku YH, Tan L, Li LS, Ding X. 1998. Role of corticotrophin-releasing factor and substance P in pressor responses of nuclei controlling emotion and stress. Peptides 19:677-682.
38. Lundberg U. 2005. Stress hormones in health and illness: the roles of work and gender. Psychoneuroendocrinology 30:1017-1021.
39. Mai JK, Assheuer J, Paxinos G. 2003. Atlas of the human brain, 2nd ed. San Diego: Academic Press/Elsevier..
40. Matthews KA, Katholi CR, McCreath H, Whooley MA, Williams DR, Zhu S, Markovitz JH. 2004. Blood pressure reactivity to psychological stress predicts hypertension in the CARDIA study. Circulation 110:74-78.
41. Men T, Brennan P, Boffetta P, Zaridze D. 2007. Russian mortality trends for 1991-2001: analysis by cause and region. BMJ 327:964-970.
42. Merali Z, Kent P, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, Bedard T, Anisman H. 2006. Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions in suicides and control subjects. Biol Psychiatry 59:594-602.
43. Merchenthaler I. 1984. Corticotropin releasing factor (CRF)-like immunoreactivity in the rat central nervous system. Extrahypothalamis distribution. Peptides 5:53-69.
44. Mihaly E, Fekete C, Lechan RM, Liposits Z. 2002. Corticotropin-releasing hormone-synthesizing neurons in the human hypothalamus receive neuropeptide Y-immunoreactive innervation from neurons residing primarily outside the infundibular nucleus. J Comp Neurol 446:235-243.
45. Moga MM, Moore RY. 1997. Organization of neural inputs to the suprachiasmatic nucleus in the rat. J Comp Neurol 389:508-534.
46. Morimoto S, Sasaki S, Miki S, Kawa T, Itoh H, Nakata T, Takeda K, Nakagawa M, Naruse S, Maeda T. 1997. Pulsatile compression of the rostral ventrolateral medulla in hypertension. Hypertension 29:514-518.
47. Mouri T, Suda T, Sasano N, Andoh N, Takei Y, Takase M, Sasaki A, Murakami O, Yoshinaga K. 1984. Immunocytochemical identification of CRH in the human hypothalamus. Tohoku J Exp Med 142:423-426.
48. Nieuwenhuyzen Kruseman AC, Linton EA, Ackland J, Besser GM, Lowry PJ. 1984. Heterogeneous immunocytochemical reactivities of oCRF-41-like material in the human hypothalamus, pituitary and gastrointestinal tract. Neuroendocrinology 38:212-216.
49. Nyklicek I, Bosch JA, Niuw Amerongen. 2005. A generalized physiological hyperreactivity to acute stressors in hypertensives. Biol Psychol 70:44-51.
50. Ohtani H, Mouri T, Sasaki A, Sasano N. 1987. Immunoelectron microscopic study of corticotropin-releasing factor in the human hypothalamus and pituitary gland. Neuroendocrinology 45:104-108.
51. Osborn JW. 2005. Hypothesis: set-points and long-term control of arterial pressure. A theoretical argument for a long-term arterial pressure control system in the brain rather than the kidney. Clin Exp Pharmacol Physiol 32:384-393.
52. Pariante CM. 2004. Glucocorticoid receptor function in vitro in patients with major depression. Stress 7:209-219.
53. Parlapiano C, Borgia MC, Minni A, Alessandri N, Basal I, Saponara M. 2005. Cortisol circadian rhythm and 24-hour Holter arterial pressure in OSAS patients. Endocr Res 31:371-374.
54. Paull WK, Phelix CF, Copeland M, Palmiter P, Gibbs FP, Middleton C. 1984. Immunohistochemical localization of corticotrophin-releasing factor (CRF) in the hypothalamus of squirrel monkey, Saimiri sciureus. Peptides 5(suppl 1):45-51.
55. Paxinos J, Huang X-F. 1995. Atlas of the human brain stem. San Diego: Academic Press.
56. Pelletier G, Desy L, Cote J, Vaudry H. 1983. Immunohistochemical localization of corticotrophin-releasing factor-like immunoreactivity in the human hypothalamus. Neurosci Lett 41:259-263.
57. Pool CW, Madlener S, Diegenbach PC, Sluiter AA, van der Sluis P. 1984. Quantification of antiserum reactivity in immunocytochemistry. J Histochem Cytochem 32:921-928.
58. Postnov YuV, Strakhov EV, Glukhovets BI, Gorkova SI. 1974. Hypothalamic neurosecretory nuclei and nucleus habenularis of epithalamus in essential hypertension. Virchows Arch A Pathol Anat Histol 364:275-283.
59. Powers RE, Walker LC, De Souza EB, Vale WW, Struble RG, Whitehouse PJ, Price DL. 1987. Immunocytochemical study of neurons containing corticotrophin-releasing factor in Alzheimer's disease. Synapse 1:405-410.
60. Quaedackers JS, Roelfsema V, Fraser M, Gunn AJ, Bennet L. 2005. Cardiovascular and endocrine effects of a single course of maternal dexamethasone treatment in preterm fetal sheep. BJOG 112:182-191.
61. Raadsheer FC, Sluiter AA, Ravid R, Tilders FJH, Swaab DF. 1993. Localization of corticotrophin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus; age-dependent colocalization with vasopressin. Brain Res 615:50-62.
62. Raadsheer FC, van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJ, Tilders FJ, Swaab DF. 1995. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry 152:1372-1376.
63. Reynolds RM, Walker BR, Syndall HE, Andrew R, Wood PJ, Whorwood CB, Philips DIW. 2001. Altered control of Cortisol secretion in adult men with low birth weight and cardiovascular risk factors. J Clin Endocrinol Metab 86:245-249.
64. Ruggiero DA, Underwood MD, Rice PM, Mann JJ, Arango V. 1999. Corticotropin-releasing hormone and serotonin interact in the human brainstem: behavioral implications. Neuroscience 91:1343-1354.
65. Sakamoto N, Pearson J, Shinoda K, Alheid GF, De Olmos JS, Heimer L. 1999. The human basal forebrain. Part 1. An overview. In: Bloom PE, Bjorklund A, Hokfelt T, editors. Handbook of chemical neuroanatomy, vol 15: The primate nervous system, part 3. Amsterdam: Elsevier Science BV. p. 1-56.
66. Saeb-Parsy K, Lombardelli S, Khan FZ, McDowall K, Au-Yong TH, Dyball REJ. 2000. Neural connections of hypothalamic neuroendocrine nuclei in the rat. J Neuroendocrinol 12:635-648.
67. Saper C. 2004. Hypothalamus. In: Paxinos G, Mai J, editors. The human nervous system. London: Elsevier. p 513-550.
68. Sholter DE, Armstrong PW. 2000. Adverse effects of corticosteroids on the cardiovascular system. Can J Cardiol 16:505-511.
69. Siggins GR, Gruol D, Aldenhoff J, Pittman Q. 1985. Electrophysiological actions of corticotrophin-releasing factor in the central nervous system. Fed Proc 44:237-242.
70. Smith PA, Meaney JFM, Graham LN, Stoker JB, Mackintosh AF, Mary DASG, Ball SG. 2004. Relationship of neurovascular compression to central sympathetic discharge and essential hypertension. J Am Coll Cardiol 43:1453-1458.
71. Swaab D. 2003. Suprachiasmatic nucleus (SCN) and pineal gland. In: Aminoff MJ, Boller F, Swaab DF, editors. The handbook of clinical neurology, vol 79 (3rd series, vol 1). The human hypothalamus: basic and clinical aspects, part 1. Amsterdam: Elsevier. p 63-125.
72. Swaab DF, Bao Ai-Min, Lucassen P. 2005. The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 4:141-149.
73. Swanson LW, Sawchenko PE, Rivier J, Vale WW. 1983. Organization of ovine corticotrophin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36:165-186.
74. Takahashi K, Mouri T, Yamamoto T, Itoi K, Murakami O, Yoshinaga K, Sasano N. 1989. Corticotropin-releasing hormone in the human hypothalamus. Free-floating immunostaining method. Endocrinol Jpn 36:275-280.
75. Timofeeva E, Richard D. 1997. Functional activation of CRH neurons and expression of the genes encoding CRH and its receptors in food-deprived lean (Fa/?) and obese (fa/fa) Zucker rats. Neuroendocrinology 66:327-340.
76. Timofeeva E, Picard F, Duclos M, Deshaies Y, Richard D. 2002. Neuronal activation and corticotrophin-releasing hormone expression in the brain of obese (fa/fa) and lean (fa/?) Zucker rats in response to refeeding. Eur J Neurosci 15:1013-1029.
77. Van der Sluis PJ, Pool CW, Sluiter AA. 1988. Immunochemical detection of peptides and proteins on press-blots after direct tissue gel isoelectric focusing. Electrophoresis 9:654-661.
78. Van der Woude PF, Goudsmit E, Wierda M, Purba JS, Hofman MA, Bogte H, Swaab DF. 1995. No vasopressin cell loss in the human hypothalamus in ageing and Alzheimer's disease. Neurobiology of ageing 16:11-18.
79. Van Oers JW, Tilders JH, Berkenbosh F. 1989. Characterization and biological activity of a rat monoclonal antibody to rat/human corticotropin-releasing factor. Endocrinology 124:1239-1246.
80. Walker BR, Philips DIW, Noon JP, Panarelli M, Andrew R, Edwards HV, Holton DW, Seckl JR, Webb DJ, Watt GCM. 1998. Increased glucocorticoid activity in men with cardiovascular risk factors. Hypertension 31:891-895.
81. Walker BR, Soderberg S, Lindahl B, Olsson T. 2000. Independent effect of obesity and cortisol in predicting cardiovascular risk factors in men and women. I Intern Med 247:198-204.
82. Weisinger RS, Blair-west JR, Burns P, Denton DA, Purcell B, Vale W, Rivier J, Weisinger HS, May CN. 2004. Cardiovascular effects of long-term central and peripheral administration of urocortin, corticotrophin-releasing factor, and adrenocorticotropin in sheep. Endocrinology 145:5598-5604.
83. Williamson PM, Tam SH, Kelly JJ, Whitworth JA. 2005. Ganglion blockade does not prevent cortisol-induced hypertension in man. Clin Exp Pharmacol Physiol
84. Yi CX, van der Vliet J, Dai J, Yin G, Ru L, Buijs RM. 2006. Ventromedial arcuate nucleus communicates peripheral metabolic information to the suprachiasmatic nucleus. Endocrinology 147:283-284.